| Year |
Citation |
Score |
| 2022 |
Bulstrode H, Girdler GC, Gracia T, Aivazidis A, Moutsopoulos I, Young AMH, Hancock J, He X, Ridley K, Xu Z, Stockley JH, Finlay J, Hallou C, Fajardo T, Fountain DM, ... ... Watts C, et al. Myeloid cell interferon secretion restricts Zika flavivirus infection of developing and malignant human neural progenitor cells. Neuron. PMID 36174572 DOI: 10.1016/j.neuron.2022.09.002 |
0.37 |
|
| 2020 |
Kremer AN, Bausenwein J, Lurvink E, Kremer AE, Rutten CE, van Bergen CAM, Kretschmann S, van der Meijden E, Honders MW, Mazzeo D, Watts C, Mackensen A, Falkenburg JHF, Griffioen M. Discovery and Differential Processing of HLA Class II-Restricted Minor Histocompatibility Antigen LB-PIP4K2A-1S and Its Allelic Variant by Asparagine Endopeptidase. Frontiers in Immunology. 11: 381. PMID 32218783 DOI: 10.3389/Fimmu.2020.00381 |
0.363 |
|
| 2018 |
Spiteri I, Caravagna G, Cresswell GD, Vatsiou A, Nichol D, Acar A, Ermini L, Chkhaidze K, Werner B, Mair R, Brognaro E, Verhaak RGW, Sanguinetti G, Piccirillo SGM, Watts C, et al. Evolutionary dynamics of residual disease in human glioblastoma. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 30452544 DOI: 10.1093/Annonc/Mdy506 |
0.315 |
|
| 2018 |
Maxan A, Mason S, Saint-Pierre M, Smith E, Ho A, Harrower T, Watts C, Tai Y, Pavese N, Savage JC, Tremblay MÈ, Gould P, Rosser AE, Dunnett SB, Piccini P, et al. Outcome of cell suspension allografts in a patient with Huntington's disease. Annals of Neurology. PMID 30286516 DOI: 10.1002/Ana.25354 |
0.612 |
|
| 2016 |
Palfi S, Gurruchaga JM, Ralph SG, Watts C, Buttery P, Lepetit H, Miskin J, Gouello G, Lavisse S, Fenelon G, Thiriez C, Brugières P, Barker R, Hantraye P, Mitrophanous K. 367. A Dopamine Gene Therapy for Advanced PD: 4 Years Phase I/II Clinical Update Molecular Therapy. 24: S147. DOI: 10.1016/S1525-0016(16)33176-8 |
0.444 |
|
| 2015 |
Piccirillo SG, Colman S, Potter NE, van Delft FW, Lillis S, Carnicer MJ, Kearney L, Watts C, Greaves M. Genetic and functional diversity of propagating cells in glioblastoma. Stem Cell Reports. 4: 7-15. PMID 25533637 DOI: 10.1016/J.Stemcr.2014.11.003 |
0.314 |
|
| 2015 |
Piccirillo SGM, Colman S, Potter NE, Delft FWv, Lillis S, Carnicer M, Kearney L, Watts C, Greaves M. Abstract 2318: Genetic and functional diversity of propagating cells in glioblastoma Cancer Research. 75: 2318-2318. DOI: 10.1158/1538-7445.Am2015-2318 |
0.312 |
|
| 2015 |
Piccirillo SGM, Colman S, Potter N, Delft Fv, Lillis S, Carnicer M, Kearney L, Watts C, Greaves M. Op14Genetic And Functional Diversity Of Propagating Cells In Glioblastoma Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov283.14 |
0.319 |
|
| 2015 |
Watts C, Piccirillo S, Colman S, Potter N, Delft Fv, Lillis S, Carnicer M, Kearney L, Francis N, Venkitaraman A, Greaves M. Atps-93Chemo-Naïve Glioblastoma Patients Contain Genetically Heterogeneous Sub-Clones Capable Of Tumour Propagation And Spatially Heterogeneous Drug-Resistant Cell Populations Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov204.93 |
0.301 |
|
| 2014 |
Palfi S, Gurruchaga JM, Ralph GS, Lepetit H, Lavisse S, Buttery PC, Watts C, Miskin J, Kelleher M, Deeley S, Iwamuro H, Lefaucheur JP, Thiriez C, Fenelon G, Lucas C, et al. Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial. Lancet. 383: 1138-46. PMID 24412048 DOI: 10.1016/S0140-6736(13)61939-X |
0.443 |
|
| 2014 |
Kolb A, Trecharichi A, Piccirillo S, Watts C, Price S. OP08 * CHARACTERISATION OF RESIDUAL CELLS IN GLIOBLASTOMA MULTIFORME Neuro-Oncology. 16: vi17-vi17. DOI: 10.1093/Neuonc/Nou251.8 |
0.305 |
|
| 2014 |
Kolb A, Watts C, Piccirillo S. Dd-06Potentiating The Therapeutic Efficiency Of The Alkylating Chemotherapy Temozolomide In Patients With Glioblastoma. Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou246.6 |
0.319 |
|
| 2014 |
Watts C, Piccirillo S, Kearney L, Potter N, Delft Fv, Coleman S, Lillis S, Carnicer M, Greaves M. Cb-18Interrogation Of Sub-Clonal Genetic Diversity Of Human Gbm Reveals Genetic Heterogeneity In Tumour-Propagating Cells, Which Display Variable Competitive Capacity For Tumour Propagation In Vivo Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou241.17 |
0.306 |
|
| 2013 |
Antoniades CA, Watts C. Huntington's disease and cell therapies: past, present, and future. Methods in Molecular Biology (Clifton, N.J.). 1010: 19-32. PMID 23754216 DOI: 10.1007/978-1-62703-411-1_2 |
0.321 |
|
| 2013 |
Barker RA, Mason SL, Harrower TP, Swain RA, Ho AK, Sahakian BJ, Mathur R, Elneil S, Thornton S, Hurrelbrink C, Armstrong RJ, Tyers P, Smith E, Carpenter A, Piccini P, ... ... Watts C, et al. The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 84: 657-65. PMID 23345280 DOI: 10.1136/Jnnp-2012-302441 |
0.614 |
|
| 2013 |
Piccirillo SGM, Spiteri I, Sottoriva A, Touloumis A, Ber S, Price SJ, Heywood R, Francis N, Collins VP, Venkitaraman AR, Curtis C, Marioni JC, Tavare S, Watts C. Abstract 5016: The human sub-ependymal zone harbors glioblastoma precursors and represents a distinct therapeutic target. Cancer Research. 73: 5016-5016. DOI: 10.1158/1538-7445.Am2013-5016 |
0.309 |
|
| 2012 |
Heywood RM, Marcus HJ, Ryan DJ, Piccirillo SG, Al-Mayhani TM, Watts C. A review of the role of stem cells in the development and treatment of glioma. Acta Neurochirurgica. 154: 951-69; discussion 9. PMID 22527576 DOI: 10.1007/S00701-012-1338-9 |
0.313 |
|
| 2012 |
Antoniades CA, Buttery P, FitzGerald JJ, Barker RA, Carpenter RH, Watts C. Deep brain stimulation: eye movements reveal anomalous effects of electrode placement and stimulation. Plos One. 7: e32830. PMID 22427894 DOI: 10.1371/Journal.Pone.0032830 |
0.412 |
|
| 2012 |
Zou F, Schmon M, Sienczyk M, Grzywa R, Palesch D, Boehm BO, Sun ZL, Watts C, Schirmbeck R, Burster T. Application of a novel highly sensitive activity-based probe for detection of cathepsin G. Analytical Biochemistry. 421: 667-72. PMID 22178917 DOI: 10.1016/J.Ab.2011.11.016 |
0.312 |
|
| 2011 |
Al-Mayhani MT, Grenfell R, Narita M, Piccirillo S, Kenney-Herbert E, Fawcett JW, Collins VP, Ichimura K, Watts C. NG2 expression in glioblastoma identifies an actively proliferating population with an aggressive molecular signature. Neuro-Oncology. 13: 830-45. PMID 21798846 DOI: 10.1093/Neuonc/Nor088 |
0.317 |
|
| 2011 |
Piccirillo SG, Watts C. Abstract 3325: Phenotypic heterogeneity and distribution of human glioblastoma tumour-initiating cells Cancer Research. 71: 3325-3325. DOI: 10.1158/1538-7445.Am2011-3325 |
0.317 |
|
| 2008 |
Clelland CD, Barker RA, Watts C. Cell therapy in Huntington disease. Neurosurgical Focus. 24: E9. PMID 18341412 DOI: 10.3171/Foc/2008/24/3-4/E8 |
0.488 |
|
| 2007 |
Joannides AJ, Webber DJ, Raineteau O, Kelly C, Irvine KA, Watts C, Rosser AE, Kemp PJ, Blakemore WF, Compston A, Caldwell MA, Allen ND, Chandran S. Environmental signals regulate lineage choice and temporal maturation of neural stem cells from human embryonic stem cells. Brain : a Journal of Neurology. 130: 1263-75. PMID 17472984 DOI: 10.1093/Brain/Awm070 |
0.31 |
|
| 2003 |
Watts C, Donovan T, Gillard JH, Antoun NM, Burnstein R, Menon DK, Carpenter TA, Fryer T, Thomas DG, Pickard JD. Evaluation of an MRI-based protocol for cell implantation in four patients with Huntington's disease. Cell Transplantation. 12: 697-704. PMID 14653617 DOI: 10.3727/000000003108747316 |
0.334 |
|
| 2002 |
Rosser AE, Barker RA, Harrower T, Watts C, Farrington M, Ho AK, Burnstein RM, Menon DK, Gillard JH, Pickard J, Dunnett SB. Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475. Journal of Neurology, Neurosurgery, and Psychiatry. 73: 678-85. PMID 12438470 DOI: 10.1136/Jnnp.73.6.678 |
0.605 |
|
| 2001 |
Manoury B, Gregory WF, Maizels RM, Watts C. Bm-CPI-2, a cystatin homolog secreted by the filarial parasite Brugia malayi, inhibits class II MHC-restricted antigen processing. Current Biology. 11: 447-451. PMID 11301256 DOI: 10.1016/S0960-9822(01)00118-X |
0.311 |
|
| 2000 |
Armstrong RJE, Watts C, Svendsen CN, Dunnett SB, Rosser AE. Survival, Neuronal Differentiation, and Fiber Outgrowth of Propagated Human Neural Precursor Grafts in an Animal Model of Huntington's Disease. Cell Transplantation. 9: 55-64. PMID 28876110 DOI: 10.1177/096368970000900108 |
0.61 |
|
| 2000 |
Watts C, Amigorena S. Antigen traffic pathways in dendritic cells. Traffic. 1: 312-317. PMID 11208116 DOI: 10.1034/J.1600-0854.2000.010404.X |
0.302 |
|
| 2000 |
Watts C, Brasted PJ, Dunnett SB. The morphology, integration, and functional efficacy of striatal grafts differ between cell suspensions and tissue pieces. Cell Transplantation. 9: 395-407. PMID 10972338 DOI: 10.1177/096368970000900310 |
0.773 |
|
| 2000 |
Brasted PJ, Watts C, Torres EM, Robbins TW, Dunnett SB. Behavioral recovery after transplantation into a rat model of Huntington's disease: dependence on anatomical connectivity and extensive postoperative training. Behavioral Neuroscience. 114: 431-6. PMID 10832803 DOI: 10.1037//0735-7044.114.2.431 |
0.765 |
|
| 2000 |
Watts C, Dunnett SB. Towards a protocol for the preparation and delivery of striatal tissue for clinical trials of transplantation in Huntington's disease. Cell Transplantation. 9: 223-34. PMID 10811395 DOI: 10.1177/096368970000900208 |
0.507 |
|
| 2000 |
Watts C, Brasted PJ, Dunnett SB. Embryonic donor age and dissection influences striatal graft development and functional integration in a rodent model of Huntington's disease. Experimental Neurology. 163: 85-97. PMID 10785447 DOI: 10.1006/Exnr.1999.7341 |
0.767 |
|
| 2000 |
Watts C, McNamara IR, Dunnett SB. Volume and differentiation of striatal grafts in rats: relationship to the number of cells implanted. Cell Transplantation. 9: 65-72. PMID 10784068 DOI: 10.1177/096368970000900109 |
0.518 |
|
| 2000 |
Armstrong RJ, Watts C, Svendsen CN, Dunnett SB, Rosser AE. Survival, neuronal differentiation, and fiber outgrowth of propagated human neural precursor grafts in an animal model of Huntington's disease. Cell Transplantation. 9: 55-64. PMID 10784067 DOI: 10.1177/096368970000900108 |
0.642 |
|
| 1999 |
Watts C. Dendritic cells spill the beans. Nature Cell Biology. 1. PMID 10559977 DOI: 10.1038/14105 |
0.304 |
|
| 1999 |
Brasted PJ, Watts C, Torres EM, Robbins TW, Dunnett SB. Behavioural recovery following striatal transplantation: effects of postoperative training and P-zone volume. Experimental Brain Research. 128: 535-8. PMID 10541748 DOI: 10.1007/S002210050877 |
0.762 |
|
| 1999 |
Brasted PJ, Watts C, Robbins TW, Dunnett SB. Associative plasticity in striatal transplants. Proceedings of the National Academy of Sciences of the United States of America. 96: 10524-9. PMID 10468642 DOI: 10.1073/Pnas.96.18.10524 |
0.763 |
|
| 1998 |
Dunnett SB, Carter RJ, Watts C, Torres EM, Mahal A, Mangiarini L, Bates G, Morton AJ. Striatal transplantation in a transgenic mouse model of Huntington's disease. Experimental Neurology. 154: 31-40. PMID 9875265 DOI: 10.1006/Exnr.1998.6926 |
0.495 |
|
| 1998 |
Manoury B, Hewitt EW, Morrice N, Dando PM, Barrett AJ, Watts C. An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation Nature. 396: 695-699. PMID 9872320 DOI: 10.1038/25379 |
0.302 |
|
| 1998 |
Watts C, Caldwell MA, Dunnett SB. The development of intracerebral cell-suspension implants is influenced by the grafting medium. Cell Transplantation. 7: 573-83. PMID 9853586 DOI: 10.1016/S0963-6897(98)00034-7 |
0.506 |
|
| 1998 |
Watts C, Dunnett SB. Effects of severity of host striatal damage on the morphological development of intrastriatal transplants in a rodent model of Huntington's disease: implications for timing of surgical intervention. Journal of Neurosurgery. 89: 267-74. PMID 9688122 DOI: 10.3171/Jns.1998.89.2.0267 |
0.523 |
|
| 1997 |
Dunnett SB, Kendall AL, Watts C, Torres EM. Neuronal cell transplantation for Parkinson's and Huntington's diseases. British Medical Bulletin. 53: 757-76. PMID 9536526 |
0.456 |
|
| 1997 |
Watts C, Dunnett SB, Rosser AE. Effect of embryonic donor age and dissection on the DARPP-32 content of cell suspensions used for intrastriatal transplantation. Experimental Neurology. 148: 271-80. PMID 9398469 DOI: 10.1006/Exnr.1997.6646 |
0.511 |
|
| 1997 |
Norbury CC, Chambers BJ, Prescott AR, Ljunggren HG, Watts C. Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells. European Journal of Immunology. 27: 280-8. PMID 9022030 DOI: 10.1002/Eji.1830270141 |
0.308 |
|
| 1994 |
Barnaba V, Watts C, Boer Md, Lane P, Lanzavecchia A. Professional presentation of antigen by activated human T cells. European Journal of Immunology. 24: 71-75. PMID 7517364 DOI: 10.1002/Eji.1830240112 |
0.3 |
|
| Show low-probability matches. |